MARCIA NIEVES: Open Payments
NPI 1780113134 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 23 payments from 11 companies in 2025. Trend: 2023 $942 · 2024 $181 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $213 |
| Intra-Sana Laboratories | 1 | $150 |
| Astellas Pharma US Inc | 3 | $68 |
| Evofem Biosciences, Inc. | 4 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Organon LLC | 2 | $44 |
| MILLICENT US INC | 2 | $37 |
| ABBVIE INC. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: RELTONE 200 MG, ANNOVERA, Veozah, Phexxi, GEMTESA, NEXPLANON, FEMLYV, UBRELVY.
Industry payments across NY — which companies pay providers there.
